2025. REDUCTION IN CONTROLLED ATTENUATION PARAMETER AND LIVER STIFFNESS WITH SAROGLITAZAR IN NAFLD: A PROSPECTIVE ANALYSIS. International Research Journal of Pharmacy. 16, 2 (Feb. 2025), 38–49. DOI:https://doi.org/10.56802/y0zhqk37.